A blood test which could help diagnose people with very early Alzheimer's disease has now been launched in the UK (November ...

Available Now: Bookings can be made now in the UK for appointments from December 2nd, introducing a biomarker blood test for clinical use for the very first time. Patient samples will be transported ...

Lucent AD, a multi-marker blood test that provides highly accurate ... Dr Simon Worrell, Founder and Chief Medical Officer of ...

Cactus leather, recycled carbon fibre and vegetal rubber: low-impact materials are the new prestige in luxury watches.

Shredding some retro phones: Alcatels, Nokia, Siemens. Enjoy the slow motion! Dolphins waive team captain, 2023 tackles ...

RNG has consistently maintained its #1 product ranking by Gartner for Large Enterprises and continues to expand its channel ...

Vanderbilt University Medical Center is receiving $3.3 million over two years through the Advanced Research Projects Agency for Health's (ARPA-H) Sprint for Women's Health for its early-stage ...

Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar competitor in Europe, after the European Commission approved Samsung Bioepis' copycat drug Byooviz. Byooviz (ranibizumab ...

Italy’s antitrust authority has launched an investigation against eight pharma companies, including Novartis and Roche, over suspicion they may have colluded to delay the launch of biosimilars ...

Nov. 13, 2024 — Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be ...

What are the future trends of medical devices? In the rapidly evolving landscape of healthcare, staying informed about the latest advancements in medical technology is essential for professionals and ...